Under the new structure, Paul Thomas, Director of Quality at Penn since 2001, will fill the newly created role of Technical Director, with overall responsibility for the company’s Technical Services Department, in addition to his current responsibilities for QA, QC, Compliance, Analytical Development and Engineering. The current Technical Services team, headed by Dr Fred Higton has been extended to include three further Technical Specialists and two Technical Writers. Pam Turner QP, Debbie Williams and Dr Rachel Hopkins will transfer to the Technical Specialists role from the current Project Management team – this move strengthens the ability of the Technical team to deliver Client support on a Technical level. All 3 are highly experienced in delivering added value technical solutions in support of Client projects. Marc Rees and Claire Davies will transfer to the position of Technical Writers also having previously supported Clients’ needs within the Project Management team. The remit of the team has also been expanded beyond Formulation Development to include all technical aspects of Client projects across all services. The Compliance Department, headed by Matthew Jaynes and the QA/QC department, led by Gaynor Langley, will continue to report to Paul. Richard Barnett Engineering Manager has been promoted to Head of Site Services/Engineering. Craig Rennie, Chief Executive at Penn Pharmaceuticals said: "In line with our ongoing commitment to periodically review our business structure, we are strengthening and raising the profile of our Technical Services offering, which will ultimately significantly enhance our ability to deliver a quality service to our Clients. "Penn is a rapidly growing international company and our strategy of becoming a leading provider of outsourced integrated drug development services is already well underway. Our enhanced technical services team will be instrumental to our continued growth within the pharmaceutical and biotech industries." Penn Pharmaceutical Services Ltd is a leading provider of outsourced pharmaceutical development services to the international healthcare industry. The company’s core business expertise includes a fully comprehensive product development service, which consists of formulation and analytical development, clinical trial manufacturing, packaging and supply management and extensive contract manufacturing. Penn also offers CMC Consultancy and Qualified Person (QP) Services.